Team Cancer Sucks to Join Forces with the Lazarex Cancer Foundation
February 11, 2020
Petaluma, CA (February 11, 2020)– Team Cancer Sucks, an organization that raises funds to help cancer patients access needed medical care is becoming a program of the Lazarex Cancer Foundation in 2020.
Team Cancer Sucks was created in 2013 with a mission to use the endurance sports platform to help cancer patients access medical care. The team made an instant splash at events due to the very “loud” race kits that they wore, which drew instant attention with its hot pink and lightning bolts design. From that point on, the Team’s following grew. To date, Team Cancer Sucks has raised over $400,000 for cancer patients. It did so with the help of the Lazarex Cancer Foundation.
“Lazarex is honored to be partnering with Team Cancer Sucks” says Vera Packard, Executive Director of the Lazarex Cancer Foundation. “We’ve loved working with them in the past and look forward to continue to work with them to help more cancer patients access needed medical treatment.”
Lazarex is the only non-profit in the United States that assists patients with finding clinical trials and reimbursing them for the travel costs to get to those clinical trials. In its 14 years, Lazarex has helped more than 5,000 patients access clinical trials.
This new partnership will allow Team Cancer Sucks to leverage Lazarex’s vast network to get more athletes to fundraise and help many more people. Everyone is encouraged to join the Team and start fundraising today.
For more information about Team Cancer Sucks please contact Chris Douglas at [email protected].
ABOUT TEAM CANCER SUCKS
Team Cancer Sucks is an endurance sports community on a mission. While training hard for group and personal success, we also race to raise funds that help cancer patients access the medical care they need to live. Why? Because cancer sucks!
Learn more about Team Cancer Sucks at www.teamcancersucks.org.
ABOUT LAZAREX CANCER FOUNDATION
Lazarex is the only non-profit in the United States that assists patients with finding clinical trials and reimburses them for the out of pocket travel costs involved in getting to those clinical trials. In its 14 years, Lazarex has helped more than 5000 patients in clinical trials. In 2018 at the urging of Lazarex, the U.S. Food and Drug Administration (FDA) changed its official guidance, issuing new language allowing pharmaceutical companies to reimburse patients for travel costs to get to clinical trials, although not all trial sponsors do this.
Learn more about Lazarex at www.lazarex.org.